As the COVID-19 pandemic continues to push frontline workers to the brim, discover how hospital employers are finding ways to meet the several demands of national nurse unions. Learn more.
Patients seeking class-action status and Sen. Richard Blumenthal are questioning the medtech's timing of the recall and outreach to patients. Philips has not quantified the impact of the suits but said it could be material.
The forecast is a bit of a bright spot for the otherwise grim financial prospects of the program, as experts worried COVID-19 would result in the fund that finances Medicare Part A running out of money faster than previously expected.
The findings from employment services firm Aon contrast sharply with this time last year, when widespread shutdowns of nonemergency care led systems to institute furloughs and other cost-cutting measures.
Use of the treatment had been halted due to weakened efficacy versus an early coronavirus variant. Now, with delta widely prevalent and demand for antibody treatments surging, Lilly's therapy will be available again.
Healthcare Dive provides in-depth journalism and insight into the most impactful news and trends shaping healthcare. The newsletters and website cover topics such as health IT, policy & regulation, insurance, digital health, payer-provider partnerships, value-based care and more. Healthcare Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries.
This email is optimized for display on mobile phones. Healthcare Dive: Daily Dive is a product of Industry Dive, Inc. 1255 23rd Street NW, Suite 550, Washington, DC 20037. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to edwardlorilla1986.acciyo123@blogger.com. You can unsubscribe or switch to a weekly newsletter subscription anytime. See our full privacy policy.
No comments:
Post a Comment